Yusuke Yamaguchi

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 16

Top Topics

Atrial Fibrillation

Chronic Kidney Disease

Inflammatory Response

Top Venues

Advances in therapy

Pharmaceutical statistics

Journal of biopharmaceutical statistics

Statistics in medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Shaka Martin, Alina Jiletcovici, Frank Dellanna, Tadao Akizawa, Jonathan Barratt
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials. Advances in therapy (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Sho Mizokawa, Yuichiro Ito, Frank Dellanna, Jonathan Barratt, Tadao Akizawa
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan. Advances in therapy 41 (4) (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Shaka Martin, Alina Jiletcovici, Frank Dellanna, Tadao Akizawa, Jonathan Barratt
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials. Advances in therapy 41 (4) (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Sho Mizokawa, Yuichiro Ito, Frank Dellanna, Jonathan Barratt, Tadao Akizawa
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan. Advances in therapy (2024)
Qing Xia, Kentaro Takeda, Yusuke Yamaguchi, Jun Zhang
A generalized Bayesian optimal interval design for dose optimization in immunotherapy. Pharmaceutical statistics (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Shaka Martin, Alina Jiletcovici, Frank Dellanna, Tadao Akizawa, Jonathan Barratt
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials. Advances in therapy 41 (4) (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Sho Mizokawa, Yuichiro Ito, Frank Dellanna, Jonathan Barratt, Tadao Akizawa
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan. Advances in therapy 41 (4) (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Sho Mizokawa, Yuichiro Ito, Frank Dellanna, Jonathan Barratt, Tadao Akizawa
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan. Advances in therapy 41 (4) (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Sho Mizokawa, Yuichiro Ito, Frank Dellanna, Jonathan Barratt, Tadao Akizawa
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan. Advances in therapy 41 (4) (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Shaka Martin, Alina Jiletcovici, Frank Dellanna, Tadao Akizawa, Jonathan Barratt
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials. Advances in therapy 41 (4) (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Shaka Martin, Alina Jiletcovici, Frank Dellanna, Tadao Akizawa, Jonathan Barratt
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials. Advances in therapy 41 (4) (2024)
Qing Xia, Kentaro Takeda, Yusuke Yamaguchi, Jun Zhang
A generalized Bayesian optimal interval design for dose optimization in immunotherapy. Pharmaceutical statistics 23 (4) (2024)
Kentaro Takeda, Jing Zhu, Ran Li, Yusuke Yamaguchi
A Bayesian optimal interval design for dose optimization with a randomization scheme based on pharmacokinetics outcomes in oncology. Pharmaceutical statistics (2023)
Yusuke Yamaguchi, Kentaro Takeda, Satoshi Yoshida, Kazushi Maruo
Optimal biological dose selection in dose-finding trials with model-assisted designs based on efficacy and toxicity: a simulation study. Journal of biopharmaceutical statistics (2023)
Yusuke Yamaguchi, Toshifumi Sugitani, Satoshi Yoshida, Kazushi Maruo
Confirmatory efficacy testing for individual dose-placebo comparisons using serial gatekeeping procedure in dose-finding trials with multiple comparison procedures-modeling. Pharmaceutical statistics 21 (6) (2022)
Yusuke Yamaguchi, Satoshi Yoshida, Toshihiro Misumi, Kazushi Maruo
Multiple imputation for longitudinal data using Bayesian lasso imputation model. Statistics in medicine 41 (6) (2022)